Research Analysts Set Expectations for DOC FY2025 Earnings

Healthpeak Properties, Inc. (NYSE:DOC - Free Report) - Equities researchers at Wedbush dropped their FY2025 EPS estimates for Healthpeak Properties in a note issued to investors on Friday, February 14th. Wedbush analyst R. Anderson now expects that the real estate investment trust will post earnings per share of $1.85 for the year, down from their previous forecast of $1.86. Wedbush has a "Outperform" rating and a $24.00 price objective on the stock. The consensus estimate for Healthpeak Properties' current full-year earnings is $1.86 per share. Wedbush also issued estimates for Healthpeak Properties' FY2026 earnings at $1.96 EPS.

A number of other analysts have also issued reports on the company. Mizuho lowered their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Thursday, December 5th. Wells Fargo & Company lowered their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 10th. Royal Bank of Canada upped their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday, October 30th. Finally, Robert W. Baird dropped their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Healthpeak Properties presently has an average rating of "Moderate Buy" and a consensus price target of $24.00.

Healthpeak Properties Price Performance

DOC stock traded up $0.29 during trading on Monday, hitting $19.79. The stock had a trading volume of 4,705,658 shares, compared to its average volume of 4,776,022. Healthpeak Properties has a twelve month low of $16.01 and a twelve month high of $23.26. The company's 50-day moving average price is $20.25 and its two-hundred day moving average price is $21.41. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market capitalization of $13.84 billion, a P/E ratio of 56.53, a PEG ratio of 2.15 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be issued a $0.305 dividend. This is a positive change from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.17%. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties's payout ratio is 348.58%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. AMF Tjanstepension AB acquired a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $15,548,000. Inspire Investing LLC purchased a new stake in Healthpeak Properties in the third quarter valued at approximately $286,000. Exchange Traded Concepts LLC acquired a new position in Healthpeak Properties during the third quarter worth $136,000. Creative Planning purchased a new position in shares of Healthpeak Properties during the third quarter worth $4,390,000. Finally, NBC Securities Inc. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $70,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.